Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics

Overview of attention for article published in European Journal of Clinical Pharmacology, January 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,034 followers.

Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics. - PubMed - NCBI https://t.co/ftOCOUcLFL

Reply Repost Favourite

Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics. https://t.co/L29XFJ980j #leukemia https://t.co/YxNGe1oozs

Reply Repost Favourite